Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Alfacell (ACEL) -- Ignore unavailable to you. Want to Upgrade?

To: Greg Kevorkian who wrote (1480)	7/17/1998 9:44:00 AM
From: Greg Kevorkian	Read Replies (1) \| Respond to of 1533

Others might be wondering whether or not VIMRx was in contact with Innovir in August. Still others might be wondering who calls the shots at the Aries Funds. Those of you who are interested in those question might want to do an EDGAR search for Aries. Scroll to Innovir filings and get ready for some very interesting reading. The single most bullish argument for holding and, perhaps, carefully adding to one's position in VIMRx is the fact that the Aries Funds now own 3,000,000 shares. As should be evident from the preceeding, these guys don't settle for a 30% or 40% return. They're more into 500+%!!! In my opinion, the days of downward manipulation of this stock (something that more than one person on this board has noticed over the past few months) is over. VIMRx shares will be strong near-term and very rewarding longer term. The technology is great, there is a vision, and management seems to have a game-plan. Don't be surprised though if this stock apprecites in value for no apparent reason...just as it depreciated in value for no apparent reason. At some point soon I believe that a lot of new investors are going to come to the party. When that happens, it won't be because "hypericin" does or doesn't work. It will be for other reasons that none of us are in a position to accurately predict at this point in time. As for me, I'm glad the Aries Funds have 3 million shares of VIMRx but there is a part of me that believes that that $3 million should be returned to VIMRx.